Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, vol.346, pp.561-565, 1990. ,
Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, vol.258, pp.1946-1955, 1992. ,
Molecular characterization of a peripheral receptor for cannabinoids, Nature, vol.365, pp.61-66, 1993. ,
Endocannabinoids in the central nervous system-an overview, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.66, pp.221-254, 2002. ,
Two new unsaturated fatty acid ethanolamides in the brain that bind to the cannabinoid receptor, J Med Chem, vol.36, pp.3032-3036, 1993. ,
identification of an endogenous 2-monoglyceride ,
, Biochem Pharmacol, vol.50, pp.83-90, 1995.
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor, Proc Natl Acad Sci, vol.98, pp.3662-3667, 2001. ,
Retrograde signaling by endocannabinoids, Curr Opin Neurobiol, vol.12, pp.324-354, 2002. ,
Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents, Neuron, vol.6, pp.565-74, 1991. ,
Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells, J Neurosci, vol.12, pp.4122-4154, 1992. ,
Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens, J Neurosci, vol.21, pp.109-125, 2001. ,
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens, Proc Natl Acad Sci, vol.99, pp.8384-8392, 2002. ,
Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system, Curr Opin Pharmacol, vol.3, pp.46-53, 2003. ,
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum, Nat Neurosci, vol.5, pp.446-51, 2002. ,
The endogenous cannabinoid system controls extinction of aversive memories, Nature, vol.418, pp.530-534, 2002. ,
SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats, Behav Pharmacol, vol.10, pp.327-358, 1999. ,
Cannabinoid pharmacology, Pharmacol Rev, vol.38, pp.151-78, 1986. ,
Unresponsivenes to cannabinoids and feduced addictive effects of opiates in CB1 receptor knockout mice, Science, vol.283, p.15, 1999. ,
Cannabinoid receptors and pain, Prog Neurobiol, vol.63, pp.569-611, 2001. ,
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A, J Pharmacol Exp Ther, vol.286, pp.1301-1309, 1998. ,
Control of pain initiation by endogenous cannabinoids, Nature, vol.394, pp.277-281, 1998. ,
Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons, J Neurosci, vol.19, pp.6795-805, 1999. ,
A second endogenous cannabinoid that modulates long-term potentiation, Nature, vol.388, pp.773-781, 1997. ,
Enhancement of memory in cannabinoid CB1 receptor knock-out mice, Eur J Pharmacol, vol.379, pp.1-2, 1999. ,
Anandamide modulates sleep and memory in rats, Brain Res, vol.812, pp.270-274, 1998. ,
Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice, Brain Res Bull, vol.45, pp.67-74, 1998. ,
Involvement of the opioid system in the anxiolytic-like effects induced by ? 9 -tetrahydrocannabinol, Psychopharmacology, vol.163, pp.111-118, 2002. ,
Delta9-tetrahydrocannabinol: Antiagressive effects in mice, rats, and squirrel monkeys, Science, vol.199, pp.1459-61, 1978. ,
An anorexic lipid mediator regulated by feeding, Nature, vol.414, pp.209-221, 2001. ,
,
, Pharmacol Ther, vol.95, pp.127-162, 2002.
Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors, Lancet, vol.353, p.560, 1999. ,
Cannabinoids in the treatment of glaucoma, Pharmacol Ther, vol.95, pp.203-223, 2002. ,
Tetrahydrocannabinol and endocannabinoids in feeding and appetite, Pharmacol Ther, vol.95, pp.185-90, 2002. ,
The endocannabinoid system as a target for therapeutic drugs, Trends Pharmacol Sci, vol.21, pp.218-242, 2000. ,
The endogenous cannabinoid system and the basal ganglia. Biochemical, pharmacological, and therapeutic aspects ,
, Pharmacol Ther, vol.95, pp.137-52, 2002.
Cannabinoids and multiple sclerosis, Pharmacol Ther, vol.95, pp.165-74, 2002. ,
Acute neuronal injury, excitotoxicity, and the endocannabinoid system ,
, Mol Neurobiol, vol.26, pp.317-363, 2002.
,